Amphastar Pharmaceuticals AMPH Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $170.94M-6.5% | $170.18M+12.2% | $216.27M+12.6% | $187.69M-1.0% | $182.78M-9.1% | ||
| $121.01M+124% | $112.64M+60.8% | $59.94M+2.7% | $44.06M+56.5% | $54.1M-38.8% | ||
| $147.85M+2.2% | $143.56M+5.3% | $146.81M+5.1% | $132.98M+1.2% | $144.64M+4.7% | ||
| $170.19M-8.2% | $176.89M+15.1% | $185.93M+42.7% | $191.73M+56.6% | $185.48M+60.6% | ||
| $633.68M+7.8% | $636.02M+19.1% | $639.47M+17.1% | $580.83M+20.3% | $587.96M+5.9% | ||
| $307.23M-0.1% | $310.57M+4.4% | $308.69M+4.5% | $310.24M+7.7% | $307.6M+6.6% | ||
| $559.62M-4.3% | $565.97M-4.2% | $572.24M-3.8% | $578.5M-3.7% | $584.53M-3.7% | ||
| $1.65B+1.3% | $1.63B+3.3% | $1.67B+7.8% | $1.62B+8.3% | $1.63B+3.3% | ||
| $152.69M-13.2% | $148.35M-5.5% | $190.84M+24.5% | $166.55M+26.9% | $175.94M+50.8% | ||
| $1.67M+646% | $1.64M+601% | $923K+266% | $927K+272% | $224K-47.7% | ||
| $164.48M-17.4% | $158.16M-9.0% | $205.23M+29.1% | $176.41M+28.8% | $199.05M-22.0% | ||
| $609.8M+1.0% | $608.75M+1.2% | $608.58M+2.0% | $607.73M+3.6% | $603.86M+1.7% | ||
| $874.77M0.0% | $840.49M-0.6% | $889.48M+8.8% | $857.85M+10.2% | $874.99M-3.0% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $673.3M+13.3% | $666.88M+17.2% | $642.45M+21.0% | $625.1M+27.5% | $594.07M+31.3% | ||
| $1.65B+1.3% | $1.63B+3.3% | $1.67B+7.8% | $1.62B+8.3% | $1.63B+3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amphastar Pharmaceuticals's total assets?
- Amphastar Pharmaceuticals (AMPH) holds $1.6B in total assets, up 1.4% year over year.
- How much cash does Amphastar Pharmaceuticals have?
- Amphastar Pharmaceuticals holds $170.9M in cash and equivalents.
- Can Amphastar Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.85 — current assets exceed current liabilities.
- Where does Amphastar Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
